• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Arch Otorhinolaryngol . Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort s

tetano

Editor, Senior Moderator
Eur Arch Otorhinolaryngol


. 2020 Aug 4.
doi: 10.1007/s00405-020-06267-2. Online ahead of print.
Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients


Serge-Daniel Le Bon[SUP] 1 [/SUP], Nathalie Pisarski[SUP] 2 [/SUP], Justine Verbeke[SUP] 2 [/SUP], L?a Prunier[SUP] 2 [/SUP], Ga?tan Cavelier[SUP] 2 [/SUP], Marie-Paule Thill[SUP] 2 [/SUP], Alexandra Rodriguez[SUP] 2 [/SUP], Didier Dequanter[SUP] 2 [/SUP], J?r?me R Lechien[SUP] 2 [/SUP], Olivier Le Bon[SUP] 3 [/SUP], Thomas Hummel[SUP] 4 [/SUP], Mihaela Horoi[SUP] 2 [/SUP]



Affiliations

Abstract

Purpose: To evaluate the evolution of chemosensation via extended psychophysical testing in patients who suffered from sudden chemosensory loss due to coronavirus disease 2019 (COVID-19). Additionally, this study sought to determine whether odor threshold testing provided additional information on olfactory loss due to COVID-19 compared to the more common odor identification testing.
Methods: Prospective cohort study of patients with sudden chemosensory loss since February 2020 and confirmed COVID-19 infection via RT-PCR or serology testing. Olfactory function was tested extensively using the "Sniffin Sticks" test battery. In addition, we screened gustatory perception and nasal cooling sensations using psychophysical tests.
Results: Seventy-two patients completed the study. After a mean of 37 days, 37% of patients showed olfactory dysfunction, 7% were dysgeusic, and 48% showed signs of low sensitivity for cooling sensation. A longer duration of anosmia before smell improvement was correlated with lower olfactory function at 5 weeks. Odor threshold detection was more affected by COVID-19 compared to odor identification.
Conclusion: Five weeks after developing sudden chemosensory loss due to COVID-19, a high proportion of patients were dysosmic and showed signs of low nasal cooling sensitivity, whereas most of them had normal taste function. SARS-CoV-2 affected mainly odor thresholds, possibly suggesting that the major cause of loss of smell lies at the level of the olfactory neuroepithelium, rather than in the central nervous system.

Keywords: COVID-19; Chemosensory loss; Psychophysical test; SARS-CoV-2.
 
Back
Top Bottom